US-based medtech Liberate Medical has raised $6.2m in a Series B financing round co-led by Scientific Health Development and an unnamed investor.
The Series B funding adds to a previous total of $1.45m raised by the company through venture financing, according to GlobalData’s deals database.
The company said it will put the funds towards its pivotal clinical trial investigating the use of its respiratory muscle stimulator device, VentFree.
